128 related articles for article (PubMed ID: 9974190)
1. Cholecystokinin receptor mechanism(s) and morphine tolerance in mice.
Zarrindast MR; Nikfar S; Rezayat M
Pharmacol Toxicol; 1999 Jan; 84(1):46-50. PubMed ID: 9974190
[TBL] [Abstract][Full Text] [Related]
2. Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms.
Rezayat M; Oreizi S; Zarrindast MR
Gen Pharmacol; 1997 Feb; 28(2):337-40. PubMed ID: 9013214
[TBL] [Abstract][Full Text] [Related]
3. Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice.
Zarrindast MR; Zabihi A; Rezayat M; Rakhshandeh H; Ghazi-Khansari M; Hosseini R
Pharmacol Biochem Behav; 1997 Sep; 58(1):173-8. PubMed ID: 9264087
[TBL] [Abstract][Full Text] [Related]
4. Role of cholecystokinin receptors in induction of antinociception in hot-plate test.
Rezayat M; Rahnavard A; Zarrindast MR
Pharmacol Toxicol; 2000 Aug; 87(2):58-62. PubMed ID: 10989941
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice.
Zarrindast MR; Malekzadeh A; Rezayat M; Ghazi-Khansari M
Pharmacol Toxicol; 1995 Dec; 77(6):360-4. PubMed ID: 8835359
[TBL] [Abstract][Full Text] [Related]
6. Interactions between antinociception induced by cholecystokinin antagonists and GABA agonists in the tail-flick test.
Zarrindast MR; Rezayat M; Ghanipoor N; Parvini S
Pharmacol Toxicol; 1998 Oct; 83(4):143-8. PubMed ID: 9820874
[TBL] [Abstract][Full Text] [Related]
7. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
8. CCK receptor activation may prevent tolerance to morphine in mice.
Rezayat M; Nikfar S; Zarrindast MR
Eur J Pharmacol; 1994 Mar; 254(1-2):21-6. PubMed ID: 8206114
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
Lu L; Huang M; Liu Z; Ma L
Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528
[TBL] [Abstract][Full Text] [Related]
10. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
Friedrich AE; Gebhart GF
J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
[TBL] [Abstract][Full Text] [Related]
11. A locus and mechanism of action for associative morphine tolerance.
Mitchell JM; Basbaum AI; Fields HL
Nat Neurosci; 2000 Jan; 3(1):47-53. PubMed ID: 10607394
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Vasar E; Harro J; Lang A; Pôld A; Soosaar A
Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
[TBL] [Abstract][Full Text] [Related]
13. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.
Lavigne GJ; Millington WR; Mueller GP
Neuropeptides; 1992 Feb; 21(2):119-29. PubMed ID: 1557183
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin and morphine-induced hypothermia.
Rezayat M; Ravandeh N; Zarrindast MR
Eur Neuropsychopharmacol; 1999 Mar; 9(3):219-25. PubMed ID: 10208291
[TBL] [Abstract][Full Text] [Related]
15. The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception.
Rattray M; Jordan CC; De Belleroche J
Eur J Pharmacol; 1988 Jul; 152(1-2):163-6. PubMed ID: 3208830
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
Legido A; Adler MW; Karkanias C; Geller EB; Bradley E; Greenstein JI; Grover WD
Neuropeptides; 1995 Feb; 28(2):107-13. PubMed ID: 7746354
[TBL] [Abstract][Full Text] [Related]
17. Possible role of cholecystokinin-A receptors in regulation of thyrotropin (TSH) secretion in male rats.
Männistö PT; Peuranen E; Harro J; Vasar E
Neuropeptides; 1992 Dec; 23(4):251-8. PubMed ID: 1475033
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effect of intracerebroventricular administration of cholecystokinin antagonist in nerve-ligated mice.
Zarrindast MR; Samiee F; Rezayat M
Pharmacol Toxicol; 2000 Oct; 87(4):169-73. PubMed ID: 11097270
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cholecystokininA receptors in bovine adrenal chromaffin cells.
Aarnisalo AM; Vainio PJ; Männistö PT; Vasar E; Tuominen RK
Neuroreport; 1996 Sep; 7(13):2167-70. PubMed ID: 8930982
[TBL] [Abstract][Full Text] [Related]
20. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
